Skip to main content

CCR5del32 in perinatal HIV-1 infection.

Publication ,  Journal Article
Rousseau, CM; Just, JJ; Abrams, EJ; Casabona, J; Stein, Z; King, MC
Published in: J Acquir Immune Defic Syndr Hum Retrovirol
December 1, 1997

CCR5, a chemokine receptor, serves as a coreceptor for macrophage-tropic HIV-1 (1-3). A 32-bp deletion within the gene encoding CCR5, CCR5del32, has been shown to prevent HIV-1 infection of T cells in the absence of a wild-type allele. This alteration is present in low frequency in Caucasian populations (4-6). To investigate the effect of CCR5del32 in perinatal HIV-1 transmission and disease progression, two cohorts of perinatally exposed infected and uninfected children were analyzed for the presence of the allele. Polymerase chain reaction (PCR) was used to identify CCR5del32 in prevalent and prospective cases among 144 African American children from New York City and 73 Caucasian children from Barcelona, Spain. HIV-1 transmission; clinical manifestations of disease, including encephalopathy, opportunistic infections, and death before 2 years of age; survival; Centers for Disease Control and Prevention (CDC) classification; and degree of immunosuppression were compared in children with and without CCR5del32. The allele frequency in HIV-1-infected African Americans (0.016) was lower than in Catalan children (0.041). No evidence for a dominant protective effect of CCR5del32 for HIV-1 transmission or disease progression was found in these cohorts.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Acquir Immune Defic Syndr Hum Retrovirol

DOI

ISSN

1077-9450

Publication Date

December 1, 1997

Volume

16

Issue

4

Start / End Page

239 / 242

Location

United States

Related Subject Headings

  • White People
  • Virology
  • Spain
  • Sequence Deletion
  • Receptors, CCR5
  • Prospective Studies
  • Prevalence
  • New York City
  • Infant
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rousseau, C. M., Just, J. J., Abrams, E. J., Casabona, J., Stein, Z., & King, M. C. (1997). CCR5del32 in perinatal HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol, 16(4), 239–242. https://doi.org/10.1097/00042560-199712010-00003
Rousseau, C. M., J. J. Just, E. J. Abrams, J. Casabona, Z. Stein, and M. C. King. “CCR5del32 in perinatal HIV-1 infection.J Acquir Immune Defic Syndr Hum Retrovirol 16, no. 4 (December 1, 1997): 239–42. https://doi.org/10.1097/00042560-199712010-00003.
Rousseau CM, Just JJ, Abrams EJ, Casabona J, Stein Z, King MC. CCR5del32 in perinatal HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 1;16(4):239–42.
Rousseau, C. M., et al. “CCR5del32 in perinatal HIV-1 infection.J Acquir Immune Defic Syndr Hum Retrovirol, vol. 16, no. 4, Dec. 1997, pp. 239–42. Pubmed, doi:10.1097/00042560-199712010-00003.
Rousseau CM, Just JJ, Abrams EJ, Casabona J, Stein Z, King MC. CCR5del32 in perinatal HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 1;16(4):239–242.

Published In

J Acquir Immune Defic Syndr Hum Retrovirol

DOI

ISSN

1077-9450

Publication Date

December 1, 1997

Volume

16

Issue

4

Start / End Page

239 / 242

Location

United States

Related Subject Headings

  • White People
  • Virology
  • Spain
  • Sequence Deletion
  • Receptors, CCR5
  • Prospective Studies
  • Prevalence
  • New York City
  • Infant
  • Humans